Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2021 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces that its Wholly-Owned Subsidiary Dialco Medical has been Granted FDA IDE Authorization to Conduct a Trial of DIMI for Home Hemodialysis Use

TORONTO, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly-owned subsidiary, Dialco Medical Inc. (“Dialco”), has been...
February 01, 2021 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Appoints Dr. John Kellum as Chief Medical Officer

TORONTO, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
January 11, 2021 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical to Present at the H.C. Wainwright Virtual BioConnect Conference

TORONTO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
January 06, 2021 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical to Present at the SNN Network Canada Virtual Event on January 7, 2021

TORONTO, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
November 27, 2020 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical to Host Virtual Investor Day on December 4, 2020

TORONTO, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
November 24, 2020 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces that its wholly owned subsidiary Dialco Medical has received MDSAP certification

MDSAP is the highest quality and regulatory standard in the medical device industry TORONTO, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a...
November 11, 2020 16:00 ET | Source: Spectral Medical Inc.

Spectral Announces Third Quarter Results

Corporate Highlights: Dialco’s DIMI receives FDA 510(k) clearance for use in hospital and clinical settings – a significant step in the full regulatory development of DIMITigris trial sites increased...
November 11, 2020 08:00 ET | Source: Spectral Medical Inc.

Spectral Medical Announces Report on Clinical Implementation of SAMI Amid COVID-19 Published in the Journal of Blood Purification

Operating the SAMI viewed as both simple and safe by the nursesSuccessful remote deployment of SAMI with only 3 hours of virtual training TORONTO, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Spectral Medical...
November 03, 2020 07:00 ET | Source: Spectral Medical Inc.

Spectral and Dialco Sponsored Symposiums at the 38th Vicenza Course on AKI and CRRT

TORONTO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) and its wholly-owned subsidiary Dialco Medical In. (“Dialco”), are pleased to announce the...
September 08, 2020 08:00 ET | Source: Spectral Medical Inc.

Spectral to Present at H.C. Wainwright & Co. 22nd Annual Global Investment Conference

TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), announced today that Dr. Paul Walker, Spectral’s Chief Executive Officer and Chris Seto,...